e-learning
resources
Copenhagen 2005
Monday 19.09.2005
Pulmonary hypertension and fibrosis: novel mechanisms
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Expression of fetal genes in pulmonary arterial hypertension
H. A. Golpon, N. Dickgreber, T. Koehnlein, T. Welte (Hannover, Germany)
Source:
Annual Congress 2005 - Pulmonary hypertension and fibrosis: novel mechanisms
Session:
Pulmonary hypertension and fibrosis: novel mechanisms
Session type:
Oral Presentation
Number:
1620
Disease area:
Interstitial lung diseases, Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
H. A. Golpon, N. Dickgreber, T. Koehnlein, T. Welte (Hannover, Germany). Expression of fetal genes in pulmonary arterial hypertension. Eur Respir J 2005; 26: Suppl. 49, 1620
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
The definition of pulmonary hypertension: history, practical implications and current controversies
Asbestosis
Related content which might interest you:
Serotonin transporter genes, pulmonary haemodynamics and pulmonary hypertension
Source: Annual Congress 2005 - Scientific year in review
Year: 2005
Contribution of angiopoietin/Tie2 pathway to pulmonary artery smooth muscle hyperplasia in idiopathic pulmonary hypertension
Source: Annual Congress 2005 - Pulmonary hypertension: pathophysiology
Year: 2005
Enhancement of pulmonary vascular remodelling and inflammatory genes with VIP gene deletion
Source: Eur Respir J 2008; 31: 135-139
Year: 2008
Gene therapeutic approaches: from stem cell therapy to gene delivery
Source: Annual Congress 2006 - Pulmonary hypertension at the crossroads of science and clinical medicine
Year: 2006
Microarray analysis of pulmonary gene expression in mice lacking the vasoactive intestinal peptide (VIP) gene: confirmation of a role in asthma and pulmonary arterial hypertension (PAH)
Source: Annual Congress 2006 - Cellular mechanisms of airway disease
Year: 2006
Iron deficiency in pulmonary arterial hypertension: a potential therapeutic target
Source: Eur Respir J 2011; 38: 1453-1460
Year: 2011
Analysis of BMPR2 gene expression in B-lymphocytes of pulmonary arterial hypertension patients
Source: International Congress 2016 – Pulmonary hypertension and pulmonary embolism: from the bench to the bedside
Year: 2016
Pulmonary arteriole gene expression signature in idiopathic pulmonary fibrosis
Source: Eur Respir J 2013; 41: 1324-1330
Year: 2013
The pathobiology and genetics of pulmonary hypertension
Source: Annual Congress 2006 - Pulmonary hypertension at the crossroads of science and clinical medicine
Year: 2006
Over expression of endothelin-1 (ET-1) in lung fibroblasts (LFb) from patients with pulmonary arterial hypertension (PAH), evidence for loss of inhibitory control
Source: International Congress 2016 – New findings in mucosal immunology
Year: 2016
Functional characterization of BMPR2 gene in pulmonary arterial hypertension
Source: International Congress 2015 – Pulmonary hypertension: rare and hereditary causes of PAH
Year: 2015
Pulmonary hypertension in children
Source: Eur Respir Mon 2012; 57: 94-107
Year: 2012
T-box protein 4
mutation causing pulmonary arterial hypertension and lung disease
Source: Eur Respir J, 54 (2) 1900388; 10.1183/13993003.00388-2019
Year: 2019
Towards an understanding of pulmonary arterial hypertension (PAH): gene regulation patterns in pulmonary arterial resistance vessels of patients with PAH
Source: Eur Respir J 2006; 28: Suppl. 50, 526s
Year: 2006
Pulmonary arterial hypertension in combined pulmonary emphysema and fibrosis
Source: Annual Congress 2005 - Pulmonary arterial hypertension diagnosis and therapy
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept